by Brandon Tudor | Sep 10, 2025 | Uncategorized
“Defining non-invasive criteria for indicating drug therapy in metabolic-associated liver disease,” published in Clinical Gastroenterology and Hepatology has these provocative lines–“Thirty-eight percent of patients (486/1281) were diagnosed with MASLD...
by Brandon Tudor | Sep 8, 2025 | Uncategorized
Consider the article “A U-shaped relationship between body mass index and the risk of elevated liver stiffness in older people: evidence from the 5-year retrospective cohort study”, published September 8, 2025 in International Journal of Obesity. Overview...
by Brandon Tudor | Sep 4, 2025 | Uncategorized
Key Quote: “As doctors, we always want to save lives — especially in this setting and in those patients who are very young,” said Wei Zhang, a transplant hepatologist at Mass General Hospital. “But we also have to balance that the organs are very sparse. The question...
by Brandon Tudor | Sep 2, 2025 | Uncategorized
Recently published content from the American Association of Clinical Endocrinology” and titled, “AACE Patient Guide to Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction–Associated Steatohepatitis (MASH),” is...
by Brandon Tudor | Aug 25, 2025 | Uncategorized
From the press release titled NHS scanning trucks help thousands get potentially life-saving liver cancer checks.”The NHS programme is targeting at-risk groups in the community, including people with high levels of alcohol consumption, a current diagnosis or...
